about
Methylglyoxal, A Metabolite Increased in Diabetes is Associated with Insulin Resistance, Vascular Dysfunction and Neuropathies.LC-MS/MS confirms that COX-1 drives vascular prostacyclin whilst gene expression pattern reveals non-vascular sites of COX-2 expressionRole of prostacyclin in pulmonary hypertension.Aspirin-triggered 15-epi-lipoxin A4 predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test.Harnessing the benefits of PPARβ/δ agonists.The Non-Genomic Effects of the PPARβδ agonist GW0742 on STZ treated rat aorta.Cross-talk between toll-like receptor 4 (TLR4) and proteinase-activated receptor 2 (PAR(2) ) is involved in vascular function.A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension.Linking phospholipase C isoforms with differentiation function in human vascular smooth muscle cells.An overview of anti-diabetic plants used in Gabon: Pharmacology and Toxicology.Thyroid Hormone Receptor Antagonists: From Environmental Pollution to Novel Small Molecules.Reply to letter regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"In silico modelling of prostacyclin and other lipid mediators to nuclear receptors reveal novel thyroid hormone receptor antagonist propertiesEvidence that diclofenac and celecoxib are thyroid hormone receptor beta antagonists
P50
Q30385523-41675F75-987C-4046-9448-9755686E3E1BQ34854231-F3659034-ED58-4E70-84E9-EEA10087B962Q35165100-F0FECFBB-4C33-47AE-86B8-BD6543E82740Q37681393-E78CAB11-CC1C-4112-B7C5-28F3AB0765FBQ38159121-FE7E7F7F-836D-4F85-8A40-FE0BF4544EA9Q39052475-DE86410D-243F-4573-A20C-74D48BE9E045Q41808688-12336193-857A-408C-8F2F-FF7236E920BBQ42933297-C82B1612-02BF-4A04-A35B-DFE1D8CE7B84Q44117989-3946EF56-91E3-4311-9621-D57F7EA87220Q47203975-A669AA4D-5CD9-443C-8412-3947534F4500Q50176330-F20D9506-AE6A-4A1D-9233-2780C004057BQ86561616-77E81AD6-BA0C-494B-B5AD-1ADFEA9ACAE9Q86943222-B90FEDA6-8A51-437B-B12B-BF7DE420DFCCQ87124731-2683F071-5DA9-41D1-A823-AAA9841DF56E
P50
description
researcher ORCID ID = 0000-0003-4271-379X
@en
name
L Harrington
@ast
L Harrington
@en
L Harrington
@nl
type
label
L Harrington
@ast
L Harrington
@en
L Harrington
@nl
prefLabel
L Harrington
@ast
L Harrington
@en
L Harrington
@nl
P31
P496
0000-0003-4271-379X